4
Changes in Ownership
Ensysce Biosciences, Inc. Filed Acc 0001192482-21-000612
Options or other derivatives
- Chief Commercial Officer acquired 349,005 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Birkett Kevin Geoffrey · Chief Commercial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-30 | Grant or award : show line 1 in the form Stock Option | +19,755 | 19,755 | D |
| 2021-06-30 | Grant or award : show line 2 in the form Stock Option | +329,250 | 329,250 | D |
Loading xslF345X03/edgar.xml…